BRESSANIN, DANIELA
BRESSANIN, DANIELA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)
Personale tecnico amm.vo
Efficacy of Systemically Administered Retargeted Oncolytic Herpes Simplex Viruses—Clearance and Biodistribution in Naïve and HSV-Preimmune Mice
2023 ANDREA VANNINI; Federico Parenti; CATIA BARBONI; Cristina Forghieri; Valerio Leoni; Mara Sanapo; Daniela Bressanin; anna zaghini; Gabriella Campadelli-Fiume; Tatiana Gianni
Genotype of Immunologically Hot or Cold Tumors Determines the Antitumor Immune Response and Efficacy by Fully Virulent Retargeted oHSV
2021 Gianni T.; Leoni V.; Sanapo M.; Parenti F.; Bressanin D.; Barboni C.; Zaghini A.; Campadelli-Fiume G.; Vannini A.
Towards a precision medicine approach and in situ vaccination against prostate cancer by psma-retargeted ohsv
2021 Vannini A.; Parenti F.; Bressanin D.; Barboni C.; Zaghini A.; Campadelli-Fiume G.; Gianni T.
MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia
2014 A. Astolfi; F. Vendemini; M. Urbini; F. Melchionda; R. Masetti; M. Franzoni; V. Libri; S. Serravalle; M. Togni; L. Montemurro; R. Rondelli; G. Paone; D. Bressanin; F. Chiarini; A.M. Martelli; R. Tonelli; A. Pession.
Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells.
2014 A.M. Martelli; A. Lonetti; F. Buontempo; F. Ricci; P.L. Tazzari; C. Evangelisti; D. Bressanin; A. Cappellini; E. Orsini; F. Chiarini.
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia
2014 Camilla Evangelisti; Cecilia Evangelisti; Francesca Chiarini; Annalisa Lonetti; Francesca Buontempo; Daniela Bressanin; Alessandra Cappellini; Ester Orsini; James A. McCubrey; Alberto Maria Martelli.
Therapeutic targeting of polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblstic leukemia.
2014 A.M. Spartà; D. Bressanin; F. Chiarini; A. Lonetti; A. Cappellini; C. Evangelisti; C. Evangelisti; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; A.M. Martelli.
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia.
2013 C. Evangelisti; C. Evangelisti; D. Bressanin; F. Buontempo; F. Chiarini; A Lonetti; M Soncin; A.M. Spartà; J. A. McCubrey; A.M. Martelli.
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia.
2012 F. Chiarini; A. Lonetti; G. Teti; E. Orsini; D. Bressanin; A.Cappellini; F. Ricci; P. L. Tazzari; A. Ognibene; M. Falconi; P. Pagliaro; I. Iacobucci; G. Martinelli; S. Amadori; J.A. McCubrey; A.M. Martelli.
Activity of the Selective IκB kinase Inhibitor BMS-345541 against T-Cell Acute Lymphoblastic Leukemia: involvement of FOXO3a
2012 F. Buontempo; F. Chiarini; D. Bressanin; G. Tabellini; F. Melchionda; A. Pession; M. Fini; L.M. Neri; J.A. McCubrey; A.M. Martelli
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia.
2012 Simioni C; Neri LM; Tabellini G; Ricci F; Bressanin D; Chiarini F; Evangelisti C; Cani A; Tazzari PL; Melchionda F; Pagliaro P; Pession A; McCubrey JA; Capitani S; Martelli AM.
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels.
2012 D. Bressanin; C. Evangelisti; F. Ricci; G. Tabellini; F. Chiarini; P.L. Tazzari; F. Melchionda; F. Buontempo; P. Pagliaro; A. Pession; J.A. McCubrey; A.M. Martelli.
Spermidine application to young developing peach fruits leads to a slowing down of ripening by impairing ripening-related ethylene and auxin metabolism and signaling
2012 P. Torrigiani; D. Bressanin; K. Ruiz Carrasco; A. Tadiello; L. Trainotti; C. Bonghi; V. Ziosi; G. Costa
Stabilization of the Escherichia coli DNA polymerase III epsilon subunit by the theta subunit favors in vivo assembly of the Pol III catalytic core
2012 Conte E; Vincelli G; Schaaper RM; Bressanin D; Stefan A; Dal Piaz F; Hochkoeppler A
Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies
2012 Alberto M Martelli;Francesca Chiarini;Camilla Evangelisti;Andrea Ognibene;Daniela Bressanin;Anna Maria Billi;Lucia Manzoli;Alessandra Cappellini;James A McCubrey
The emerging multiple roles of nuclear Akt.
2012 A.M. Martelli; G. Tabellini; D. Bressanin; A. Ognibene; K. Goto; L. Cocco; C. Evangelisti.
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment.
2012 A.M. Martelli; F. Chiarini; C. Evangelisti; A. Cappellini; F. Buontempo; D. Bressanin; M. Fini; J.A. McCubrey
Nuclear phosphoinositides and their roles in cell biology and disease.
2011 Martelli A.M.; Ognibene A.; Buontempo F.; Fini M.; Bressanin D.; Goto K.; McCubrey J.A.; Cocco L.; Evangelisti C.
Proteolysis of the proofreading subunit controls the assembly of Escherichia coli DNA polymerase III catalytic core.
2009 Bressanin D.; Stefan A.; Dal Piaz F.; Cianchetta S.; Reggiani L.; Hochkoeppler A.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Efficacy of Systemically Administered Retargeted Oncolytic Herpes Simplex Viruses—Clearance and Biodistribution in Naïve and HSV-Preimmune Mice | ANDREA VANNINI; Federico Parenti; CATIA BARBONI; Cristina Forghieri; Valerio Leoni; Mara Sanapo; ...Daniela Bressanin; anna zaghini; Gabriella Campadelli-Fiume; Tatiana Gianni | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | ONCOLITICI cancers-15-04042.pdf |
| Genotype of Immunologically Hot or Cold Tumors Determines the Antitumor Immune Response and Efficacy by Fully Virulent Retargeted oHSV | Gianni T.; Leoni V.; Sanapo M.; Parenti F.; Bressanin D.; Barboni C.; Zaghini A.; Campadelli-Fium...e G.; Vannini A. | 2021-01-01 | VIRUSES | - | 1.01 Articolo in rivista | viruses-13-01747.pdf; viruses-13-01747-s001.zip |
| Towards a precision medicine approach and in situ vaccination against prostate cancer by psma-retargeted ohsv | Vannini A.; Parenti F.; Bressanin D.; Barboni C.; Zaghini A.; Campadelli-Fiume G.; Gianni T. | 2021-01-01 | VIRUSES | - | 1.01 Articolo in rivista | viruses-13-02085.pdf |
| MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia | A. Astolfi; F. Vendemini; M. Urbini; F. Melchionda; R. Masetti; M. Franzoni; V. Libri; S. Serrava...lle; M. Togni; L. Montemurro; R. Rondelli; G. Paone; D. Bressanin; F. Chiarini; A.M. Martelli; R. Tonelli; A. Pession. | 2014-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | - |
| Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells. | A.M. Martelli; A. Lonetti; F. Buontempo; F. Ricci; P.L. Tazzari; C. Evangelisti; D. Bressanin; A.... Cappellini; E. Orsini; F. Chiarini. | 2014-01-01 | ADVANCES IN BIOLOGICAL REGULATION | - | 1.01 Articolo in rivista | - |
| Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia | Camilla Evangelisti; Cecilia Evangelisti; Francesca Chiarini; Annalisa Lonetti; Francesca Buontem...po; Daniela Bressanin; Alessandra Cappellini; Ester Orsini; James A. McCubrey; Alberto Maria Martelli. | 2014-01-01 | INTERNATIONAL JOURNAL OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Therapeutic targeting of polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblstic leukemia. | A.M. Spartà; D. Bressanin; F. Chiarini; A. Lonetti; A. Cappellini; C. Evangelisti; C. Evangelisti...; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; A.M. Martelli. | 2014-01-01 | CELL CYCLE | - | 1.01 Articolo in rivista | - |
| Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia. | C. Evangelisti; C. Evangelisti; D. Bressanin; F. Buontempo; F. Chiarini; A Lonetti; M Soncin; A.M.... Spartà; J. A. McCubrey; A.M. Martelli. | 2013-01-01 | EXPERT OPINION ON THERAPEUTIC TARGETS | - | 1.01 Articolo in rivista | - |
| A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia. | F. Chiarini; A. Lonetti; G. Teti; E. Orsini; D. Bressanin; A.Cappellini; F. Ricci; P. L. Tazzari;... A. Ognibene; M. Falconi; P. Pagliaro; I. Iacobucci; G. Martinelli; S. Amadori; J.A. McCubrey; A.M. Martelli. | 2012-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | - |
| Activity of the Selective IκB kinase Inhibitor BMS-345541 against T-Cell Acute Lymphoblastic Leukemia: involvement of FOXO3a | F. Buontempo; F. Chiarini; D. Bressanin; G. Tabellini; F. Melchionda; A. Pession; M. Fini; L.M. N...eri; J.A. McCubrey; A.M. Martelli | 2012-01-01 | CELL CYCLE | - | 1.01 Articolo in rivista | - |
| Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. | Simioni C; Neri LM; Tabellini G; Ricci F; Bressanin D; Chiarini F; Evangelisti C; Cani A; Tazzari... PL; Melchionda F; Pagliaro P; Pession A; McCubrey JA; Capitani S; Martelli AM. | 2012-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels. | D. Bressanin; C. Evangelisti; F. Ricci; G. Tabellini; F. Chiarini; P.L. Tazzari; F. Melchionda; F.... Buontempo; P. Pagliaro; A. Pession; J.A. McCubrey; A.M. Martelli. | 2012-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | - |
| Spermidine application to young developing peach fruits leads to a slowing down of ripening by impairing ripening-related ethylene and auxin metabolism and signaling | P. Torrigiani; D. Bressanin; K. Ruiz Carrasco; A. Tadiello; L. Trainotti; C. Bonghi; V. Ziosi; G.... Costa | 2012-01-01 | PHYSIOLOGIA PLANTARUM | - | 1.01 Articolo in rivista | - |
| Stabilization of the Escherichia coli DNA polymerase III epsilon subunit by the theta subunit favors in vivo assembly of the Pol III catalytic core | Conte E; Vincelli G; Schaaper RM; Bressanin D; Stefan A; Dal Piaz F; Hochkoeppler A | 2012-01-01 | ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS | - | 1.01 Articolo in rivista | - |
| Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies | Alberto M Martelli;Francesca Chiarini;Camilla Evangelisti;Andrea Ognibene;Daniela Bressanin;Anna ...Maria Billi;Lucia Manzoli;Alessandra Cappellini;James A McCubrey | 2012-01-01 | EXPERT OPINION ON THERAPEUTIC TARGETS | - | 1.01 Articolo in rivista | - |
| The emerging multiple roles of nuclear Akt. | A.M. Martelli; G. Tabellini; D. Bressanin; A. Ognibene; K. Goto; L. Cocco; C. Evangelisti. | 2012-01-01 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | - | 1.01 Articolo in rivista | - |
| Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. | A.M. Martelli; F. Chiarini; C. Evangelisti; A. Cappellini; F. Buontempo; D. Bressanin; M. Fini; J....A. McCubrey | 2012-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | - |
| Nuclear phosphoinositides and their roles in cell biology and disease. | Martelli A.M.; Ognibene A.; Buontempo F.; Fini M.; Bressanin D.; Goto K.; McCubrey J.A.; Cocco L....; Evangelisti C. | 2011-01-01 | CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY | - | 1.01 Articolo in rivista | - |
| Proteolysis of the proofreading subunit controls the assembly of Escherichia coli DNA polymerase III catalytic core. | Bressanin D.; Stefan A.; Dal Piaz F.; Cianchetta S.; Reggiani L.; Hochkoeppler A. | 2009-01-01 | BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS | - | 1.01 Articolo in rivista | - |